Group One Trading’s Raptor Pharmaceutical RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-160,615
Closed -$1.44M – 5319
2016
Q3
$1.44M Sell
160,615
-218,869
-58% -$1.56M 0.02% 1029
2016
Q2
$2.04M Sell
379,484
-41,380
-10% -$212K 0.02% 820
2016
Q1
$1.94M Sell
420,864
-513,419
-55% -$2.06M 0.03% 788
2015
Q4
$4.86M Sell
934,283
-331,147
-26% -$1.92M 0.06% 381
2015
Q3
$7.66M Sell
1,265,430
-54,336
-4% -$666K 0.11% 213
2015
Q2
$20.8M Buy
1,319,766
+265,937
+25% +$3.23M 0.29% 53
2015
Q1
$11.5M Buy
1,053,829
+331,266
+46% +$3.38M 0.18% 86
2014
Q4
$7.6M Buy
722,563
+32,971
+5% +$322K 0.11% 173
2014
Q3
$6.61M Sell
689,592
-370,295
-35% -$3.78M 0.1% 212
2014
Q2
$12.2M Buy
1,059,887
+79,585
+8% +$725K 0.19% 85
2014
Q1
$9.8M Buy
980,302
+640,155
+188% +$9.24M 0.16% 106
2013
Q4
$4.43M Buy
+340,147
New +$4.68M 0.07% 297

Group One Trading's RPTP Position: Q4 2016 in Review

Group One Trading sold out of Raptor Pharmaceutical (RPTP) in Q4 2016, closing a stake of 160,615 shares — an estimated $1.44M sold.

Group One Trading first reported a position in RPTP in Q4 2013 and held it in 12 quarters. The position peaked at $20.8M in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Group One Trading reported no remaining Raptor Pharmaceutical position as of Q4 2016 after selling out during the quarter.
  • Group One Trading sold 160,615 Raptor Pharmaceutical shares in Q4 2016, an estimated $1.44M.
  • Group One Trading first reported a position in Raptor Pharmaceutical in Q4 2013 and held it in 12 quarters.
  • Group One Trading's Raptor Pharmaceutical position peaked at $20.8M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held Raptor Pharmaceutical as of Q4 2016.

Based on Group One Trading's 13F filing for Q4 2016, filed 15 Feb 2017.